Health News Articles

Excerpts of key news articles on

Below are key excerpts of revealing news articles on health from reliable news media sources. If any link fails to function, a paywall blocks full access, or the article is no longer available, try these digital tools.

For further exploration, delve into our comprehensive Health and Food Corruption Information Center.

Note: Explore our full index to revealing excerpts of key major media news articles on dozens of engaging topics. And read excerpts from 20 of the most revealing news articles ever published.

Social isolation is a growing epidemic — one that’s increasingly recognized as having dire physical, mental and emotional consequences. Since the 1980s, the percentage of American adults who say they’re lonely has doubled from 20 percent to 40 percent. About one-third of Americans older than 65 now live alone, and half of those over 85 do. People in poorer health — especially those with mood disorders like anxiety and depression — are more likely to feel lonely. Those without a college education are the least likely to have someone they can talk to about important personal matters. A wave of new research suggests social separation is bad for us. Individuals with less social connection have disrupted sleep patterns, altered immune systems, more inflammation and higher levels of stress hormones. One recent study found that isolation increases the risk of heart disease by 29 percent and stroke by 32 percent. Another analysis that pooled data from 70 studies and 3.4 million people found that socially isolated individuals had a 30 percent higher risk of dying in the next seven years, and that this effect was largest in middle age. Loneliness can accelerate cognitive decline in older adults, and isolated individuals are twice as likely to die prematurely as those with more robust social interactions. These effects start early: Socially isolated children have significantly poorer health 20 years later. All told, loneliness is as important a risk factor for early death as obesity and smoking.

Note: For more along these lines, see concise summaries of deeply revealing news articles on health from reliable major media sources.

After three tours in Iraq and Afghanistan, C. J. Hardin wound up hiding from the world. He had tried almost all the accepted treatments for post-traumatic stress disorder. “Nothing worked for me,” said Mr. Hardin. Then, in 2013, he joined a small drug trial testing whether PTSD could be treated with MDMA, the illegal party drug better known as Ecstasy. “It changed my life,” he said. “It allowed me to see my trauma without fear or hesitation and finally process things and move forward.” Based on promising results like Mr. Hardin’s, the Food and Drug Administration gave permission Tuesday for large-scale, Phase 3 clinical trials of the drug - a final step before the possible approval of Ecstasy as a prescription drug. The Multidisciplinary Association for Psychedelic Studies, a small nonprofit created in 1985 ... sponsored six Phase 2 studies treating a total of 130 PTSD patients. Two trials ... focused on treating combat veterans, sexual assault victims, and police and firefighters with PTSD who had not responded to traditional prescription drugs or psychotherapy. Patients had, on average, struggled with symptoms for 17 years. After three doses of MDMA administered under a psychiatrist’s guidance, the patients reported a 56 percent decrease of severity of symptoms on average, one study found. By the end of the study, two-thirds no longer met the criteria for having PTSD. Follow-up examinations found that improvements lasted more than a year after therapy.

Note: Read more about how MDMA has been found effective for treating PTSD in a therapeutic context. This FDA approval to begin Phase 3 clinical trials of MDMA suggests that the healing potentials of mind-altering drugs are gaining mainstream scientific credibility.

The American Heart Association and the American College of Cardiology released new guidelines for prescribing cholesterol-lowering medicines. The big winners are expected to be the drug makers that sell statins, since other types of pills were not recommended. Of the 15 panelists that authored these new guidelines, six reported having recent or current ties to drugmakers that already sell or are developing cholesterol medications. And among the half dozen who disclosed these relationships was one of the two panel co-chairs, which contradicts an Institute of Medicine suggestion about managing conflicts and leadership roles on such panels. To be specific, the Institute of Medicine wrote that, “whenever possible, guideline development group members should not have conflicts of interest ... and the chair or co-chairs should not be a person(s) with conflicts of interest.” The Institute of Medicine also wrote that members with conflicts should not represent a majority (here is the IOM report). “One of the reasons the IOM recently recommended eliminating rather than ‘managing’ financial conflicts of interest in guideline development groups is because of concerns about implicit bias,” says Lisa Cosgrove ... at the University of Massachusetts. “When individuals have commercial ties they are vulnerable to developing subtle, but sometimes powerful, pro-industry ways of thinking. Transparency ... can actually worsen the problem, because some people think simply disclosing a tie relieves any moral concern.”

Note: For lots more on this, see an informative article titled "The Statin Mafia Censors Pharmaceutical Harm." For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.

Professor John Lorber ... was not jesting totally when he addressed a conference of pediatricians with a paper entitled "Is your brain really necessary?" "There's a young student at this university," says Lorber, "who has an IQ of 126, has gained a first-class honors degree in mathematics, and is socially completely normal. And yet the boy has virtually no brain." The student's physician at the university noticed that the youth had a slightly larger than normal head, and so referred him to Lorber, simply out of interest. "When we did a brain scan on him," Lorber recalls, "we saw that instead of the normal 4.5-centimeter thickness of brain tissue between the ventricles and the cortical surface, there was just a thin layer of mantle measuring a millimeter or so. His cranium is filled mainly with cerebrospinal fluid." Startling as it may seem, this case is nothing new to the medical world. A substantial proportion of patients appear to escape functional impairment in spite of grossly abnormal brain structure. Lorber concludes from these observations that "there must be a tremendous amount of redundancy or spare capacity in the brain, just as there is with kidney and liver." He also contends that "the cortex probably is responsible for a great deal less than most people imagine. For hundreds of years neurologists have assumed that all that is dear to them is performed by the cortex, but it may well be that the deep structures in the brain carry out many of the functions assumed to be the sole province of the cortex."

Note: For more along these lines, see concise summaries of deeply revealing news articles on health and the mysterious nature of reality from reliable major media sources.

Did you ever feel your own shoulders relax when you saw a friend receive a shoulder massage? For those of you who said "yes," congratulations, your brain is using its power to create a "placebo effect." For those who said "no," you're not alone, but thankfully, the brain is trainable. Since the 1800s, the word placebo has been used to refer to a fake treatment, meaning one that does not contain any active, physical substance. Today, placebos play a crucial role in medical studies in which some participants are given the treatment containing the active ingredients of the medicine, and others are given a placebo. These types of studies help tell researchers which medicines are effective, and how effective they are. Surprisingly, however, in some areas of medicine, placebos themselves provide patients with clinical improvement. Research suggests that the placebo effect is caused by positive expectations, the provider-patient relationship and the rituals around receiving medical care. Depression, pain, fatigue, allergies, irritable bowel syndrome, Parkinson's disease and even osteoarthritis of the knee are just a few of the conditions that respond positively to placebos. In addition to the ever-increasing body of evidence surrounding their effectiveness, placebos offer multiple benefits. They have no side effects. They are cheap. They are not addictive. They provide hope when there might not be a specific chemically active treatment available. They mobilize a person's own ability to heal through multiple pathways.

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

The reminders of pandemic-driven suffering among students in Clark County, Nev., have come in droves. Since schools shut their doors in March, an early-warning system that monitors students' mental health episodes has sent more than 3,100 alerts to district officials, raising alarms about suicidal thoughts, possible self-harm or cries for care. By December, 18 students had taken their own lives. The spate of student suicides in and around Las Vegas has pushed the Clark County district, the nation's fifth largest, toward bringing students back as quickly as possible. This month, the school board gave the green light to phase in the return of some elementary school grades and groups of struggling students. Over the summer ... Dr. Robert R. Redfield, then the C.D.C. director, warned that a rise in adolescent suicides would be one of the "substantial public health negative consequences" of school closings. Mental health advocacy groups warned that the student demographics at the most risk for mental health declines before the pandemic – such as Black children and L.G.B.T.Q. students – were among those most marginalized by the school closures. But given the politically charged atmosphere this summer, many of those warnings were dismissed as scare tactics. Parents of students who have taken their lives say connecting suicide to school closings became almost taboo.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus and health from reliable major media sources.

President Trump’s enthusiastic embrace of a malaria drug that he now says he takes daily — and the resulting uproar in the news media — appears to be interfering with legitimate scientific research into whether the medicine might work to prevent coronavirus infection or treat the disease. The drug, hydroxychloroquine ... is also widely used to treat lupus and other autoimmune diseases. But specialists — including Dr. Anthony S. Fauci, the government’s top infectious disease expert — say the jury is still out. Mr. Trump’s frequent pronouncements and misstatements — he has praised the drug as a “game changer” and a “miracle” — are only complicating matters. Last week, the National Institute of Allergy and Infectious Diseases, which Dr. Fauci leads, announced a 2,000-patient study to determine whether hydroxychloroquine, when combined with the antibiotic azithromycin, “can prevent hospitalization and death from Covid-19,” joining more than 50 other clinical trials that are continuing in the United States. Researchers around the country said the controversy was depressing enrollment in their clinical trials. The president’s trade adviser, Peter Navarro ... said “hydroxy hysteria” in the news media — not Mr. Trump — was to blame. “Has the media’s war of hysteria on hydroxychloroquine killed people?” Mr. Navarro asked in an interview. “If the scientific evidence does indeed prove that the medicine has both prophylactic and therapeutic value, the answer is yes.”

Note: In a survey reported in this New York Post article, over 2,000 physicians were asked which drug was most effective in treating the coronavirus. Hydroxychloroquine was chosen by the greatest number of those surveyed (37%). Remember that chlorequine has already been proven safe for other illnesses and is very cheap as the patent expired. So big Pharma, who are huge sponsors of the media, don't like this drug. For more along these lines, see concise summaries of deeply revealing news articles on media corruption and the coronavirus from reliable major media sources.

The facts are this: COVID-19 is a real disease that sickens some, proves fatal to others, mostly the elderly — and does nothing to the vast majority. That, in a nutshell, is it. The response to the coronavirus is hyped. And in time, this hype will be revealed as politically hoaxed. Or, in the words of Dan Erickson and Artin Massih, doctors and co-owners of Accelerated Urgent Care in Bakersfield, California: Let’s get the country reopened. “Do we need to still shelter in place? Do we need businesses to be shut down? Our answer is emphatically no" ... Erickson said. The scientists leading the coronavirus shutdown charge [based their] estimates on computer modeling. But at the same time ... they were acknowledging that computer modeling is inaccurate and errs on the side of hype. But from these faulty overinflated computer figures came all the constitutionally questionable actions by government — from ordering businesses closed to quarantining-slash-house arresting American citizens to doing some quick and pitiful and economically painful income redistribution schemes via stimulus funds’ legislation. This virus was far more contagious than anything ever before seen or studied, Americans were told. And any time the case counts dropped off and the numbers proved wrong, well, this was due to the social distancing and quarantining and face-mask wearing that Americans had been doing — Americans were told. “When I’m writing up my death report I’m being pressured to add COVID. Why is that? If you’re going to dance on someone’s constitutional rights, you better have a good reason — you better have a really good reason, not just a theory,” Erickson said.

Note: We don't consider the Washington Times to be a highly reliable source, but occasionally they report on key matters that other media fail to report, as is the case with this one. For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

Johns Hopkins Medicine announced the launch of the Center for Psychedelic and Consciousness Research, to study compounds like LSD and psilocybin for a range of mental health problems, including anorexia, addiction and depression. The center is the first of its kind in the country, established with $17 million in commitments from wealthy private donors and a foundation. The centers at Johns Hopkins and Imperial College give “psychedelic medicine,” as some call it, a long-sought foothold in the scientific establishment. Since the early 2000s, several scientists have been exploring the potential of psychedelics and other recreational drugs for psychiatric problems, and their early reports have been tantalizing. The emergence of depression treatment with the anesthetic and club drug ketamine and related compounds, which cause out-of-body sensations, also has piqued interest in mind-altering agents as aids to therapy. The ... funding will help clarify which drugs help which patients. Roland Griffiths, a neuroscientist at Johns Hopkins who will direct the new center ... said the new funds will cover six full-time faculty, five postdoctoral scientists and the costs of running trials. Among the first of those trials are a test of psilocybin for anorexia nervosa and of psilocybin for psychological distress and cognitive impairment in early Alzheimer’s disease. “The one that’s crying out to be done is for opiate-use disorder, and we also plan to look at that,” Dr. Griffiths said.

Note: Learn about the fascinating man who is bankrolling a significant portion of this new center in this New York Times article. For more along these lines, see concise summaries of deeply revealing news articles on mind-altering drugs from reliable major media sources.

Three pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high, California Attorney General Xavier Becerra said. The bulk of the money will come from Teva Pharmaceutical Industries Ltd. and its affiliates for paying to delay a generic narcolepsy drug, Provigil, from entering the market for nearly six years. Teva is paying $69 million, which Becerra says is the largest pay-for-delay settlement received by any state. Such agreements let the developer of brand name drugs keep their monopolies over the drugs after their patents expire, thereby letting them continue to charge consumers higher prices. The drug developer pays the generic manufacturer to keep the cheaper version of the drug from entering the marketplace for an agreed period of time. Such agreements can force consumers and the health care market to pay as much as 90% more than if there were generic alternatives. More than $25 million of the settlement will go to a consumer fund for California residents who purchased Provigil, Nuvigil or Modafinil between 2006 and 2012. The second, $760,000 settlement is with Teva, Endo Pharmaceuticals and Teikoku Pharma USA over keeping a genetic alternative to the pain patch Lidoderm from entering the market for nearly two years. Both settlements bar the companies from pay-for-delay agreements for several years.

Note: They are only barred from pay-for-delay agreements for several years? Shouldn't this practice be illegal? For more along these lines, see concise summaries of deeply revealing news articles on pharmaceutical industry corruption from reliable major media sources.

All of us have had the experience of wandering through a lush garden or a timeless desert, walking by a river or an ocean, or climbing a mountain and finding ourselves simultaneously calmed and reinvigorated. The importance of these physiological states on individual and community health is fundamental and wide-ranging. In 40 years of medical practice, I have found only two types of non-pharmaceutical “therapy” to be vitally important for patients with chronic neurological diseases: music and gardens. I cannot say exactly how nature exerts its calming and organizing effects on our brains, but I have seen in my patients the restorative and healing powers of nature and gardens, even for those who are deeply disabled neurologically. In many cases, gardens and nature are more powerful than any medication. My friend Lowell has moderately severe Tourette’s syndrome. In his usual busy, city environment, he has hundreds of tics and verbal ejaculations each day - grunting, jumping, touching things compulsively. I was therefore amazed one day when we were hiking in a desert to realize that his tics had completely disappeared. The remoteness and uncrowdedness of the scene, combined with some ineffable calming effect of nature, served to defuse his ticcing, to “normalize” his neurological state. The effects of nature’s qualities on health are not only spiritual and emotional but physical and neurological. I have no doubt that they reflect deep changes in the brain’s physiology, and perhaps even its structure.

Note: The above is excerpted from “Everything in Its Place,” a posthumous collection of writings by Dr. Oliver Sacks. Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

It looks like an ordinary commercial warehouse, only much bigger. When the lights come on, hundreds of thousands of shrink-wrapped boxes of medicines emerge from the gloom, stacked on shelves nearly five stories high. This [warehouse] and several others across the country are part of the $7 billion Strategic National Stockpile, a government repository of drugs and supplies ready for deployment in a bioterrorism or nuclear attack, or ... other major public health emergency. For nearly two decades, the repository has been almost exclusively managed by the Centers for Disease Control and Prevention. That will change under a Trump administration plan to shift oversight of the $575 million program. Public health officials and members of Congress ... worry the move will disrupt a complex process that relies on long-standing relationships. Experts also question whether the administration’s plan will politicize decision-making about products bought for the stockpile. The office of the assistant secretary for preparedness and response (ASPR) oversees the process by which the government awards contracts to private biotechnology companies that develop and manufacture medicines. The CDC then is responsible for buying and replenishing the materials. Come October, however, the ASPR will be in charge of choosing the products and then purchasing them for the stockpile. Critics say it will allow biotech companies to lobby for more of their specialized, and often more expensive, drugs to be included.

Note: With a $7 billion price tag, big Pharma is making money hands over fist on this repository which is almost never used. Most of these drugs have a shelf life of well under 10 years, so major parts of this huge inventory go to waste every year and have to be disposed of. For more along these lines, see concise summaries of deeply revealing news articles on government corruption and Big Pharma profiteering from reliable major media sources.

For generations of most American families, getting children vaccinated was just something to check off on the list of back-to-school chores. But after the ferocious battles over Covid shots of the past two years, simmering resistance to general school vaccine mandates has grown significantly. Now, 35 percent of parents oppose requirements that children receive routine immunizations in order to attend school, according to a new survey released Friday by the Kaiser Family Foundation. Forty-four percent of adults who either identify as Republicans or lean that way said in the latest survey that parents should have the right to opt out of school vaccine mandates, up from 20 percent in a prepandemic poll conducted in 2019 by the Pew Research Center. In contrast, 88 percent of adults who identify as or lean Democratic endorsed childhood vaccine requirements, a slight increase from 86 percent in 2019. The survey found that 28 percent of adults overall believed parents should have the authority to make school vaccine decisions for their children, a stance that in the 2019 Pew poll was held by just 16 percent of adults. The shift in positions appears to be less about rejecting the shots than a growing endorsement of the so-called parents' rights movement. Indeed, 80 percent of parents said that the benefits of vaccines for measles, mumps and rubella outweighed the risks, down only slightly from 83 percent in 2019. The latest survey was based on interviews with a nationally representative sample of 1,259 adults.

Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

Eating colorful fruits and vegetables may be good for your brain. A new study, one of the largest such analyses to date, has found that flavonoids, the chemicals that give plant foods their bright colors, may help curb the frustrating forgetfulness and mild confusion that older people often complain about with advancing age, and that sometimes can precede a diagnosis of dementia. The study was observational so cannot prove cause and effect, though its large size and long duration add to growing evidence that what we eat can affect brain health. The scientists used data from two large continuing health studies that began in the late 1970s and early 1980s, in which participants periodically completed diet and health questionnaires over more than 20 years. The analysis included 49,693 women whose average age was 76, and 51,529 men whose average age was 73. The scientists calculated their intake of about two dozen commonly consumed kinds of flavonoids – which include beta carotene in carrots, flavone in strawberries, anthocyanin in apples, and other types in many other fruits and vegetables. The study appears in the journal Neurology. According to the senior author, Dr. Deborah Blacker ... these long-term findings suggest that starting early in life with a flavonoid-rich diet may be important for brain health. For young people and those in midlife, she said, "the message is that these things are good for you in general, and not just for cognition. Finding ways that you enjoy incorporating these things into your life is important."

Note: Explore a treasure trove of concise summaries of incredibly inspiring news articles which will inspire you to make a difference.

The COVID-19 vaccines' second dose can pack a heavy punch. But while most people experience flu-like symptoms and complain of a sore arm, musician and anti-lockdown activist Eric Clapton says his side effects included frozen limbs. Clapton wrote a note recently to Italian architect Robin Monotti Graziadei, who has shared numerous anti-lockdown posts on social media, where he called his experience receiving the AstraZeneca vaccine "disastrous." The former Cream guitarist said he got the vaccine in February. "I took the first jab of AZ and straight away had severe reactions which lasted ten days, I recovered eventually and was told it would be twelve weeks before the second one," Clapton wrote. "About six weeks later I was offered and took the second AZ shot," he continued. "Needless to say the reactions were disastrous, my hands and feet were either frozen, numb or burning, and pretty much useless for two weeks, I feared I would never play again, (I suffer with peripheral neuropathy and should never have gone near the needle.) But the propaganda said the vaccine was safe for everyone." The side effects of the AstraZeneca vaccine – which has not been approved yet for use in the U.S. – are described by the U.K. government as "mild to moderate in nature" and are expected to go away after a few days.

Note: For more along these lines, see concise summaries of deeply revealing news articles on coronavirus vaccines from reliable major media sources.

In total 2,487 people have died of the coronavirus in Japan, just over half the number in China and fewer people than on a single day in America several times over the past week. Japan has suffered just 18 deaths per million people, a higher rate than in China, but by far the lowest in the G7. As early as March, Japanese officials began warning citizens to avoid the san-mitsu or "3Cs": closed spaces, crowded places and close-contact settings. The phrase was blasted across traditional and social media. Authorities [made] granular distinctions about risks, opting for targeted restrictions rather than swinging between the extremes of strict lockdowns and free-for-all openings. Nishimura Yasutoshi, the minister overseeing the government's response to covid-19, carries a device that monitors carbon dioxide to measure the quality of ventilation during his meetings. Crowded subways pose little risk, if windows are open and passengers wear masks, Mr Nishimura insists. Sitting diagonally, rather than directly across from each other can reduce the risk of infection by 75%. Movie theatres are safe ... Mr Nishimura says. While most cinemas in the West are closed, "Demon Slayer", a new animeflick, has been playing to full houses in Japan. In addition to the 3Cs, the Japanese government warns of five more specific dangers: dinner parties with booze; drinking and eating in groups of more than four; talking without masks at close quarters; living in dormitories and other small shared spaces; and using changing or break rooms.

Note: For more along these lines, see concise summaries of deeply revealing news articles on the coronavirus from reliable major media sources.

For weeks, the world has been inundated with information about the COVID-19 pandemic. While cases continue to rise and researchers learn more about the novel coronavirus (SARS-CoV-2), most data has lacked a certain specificity. But on Tuesday, the Centers for Disease Control and Prevention (CDC) was able to give a closer look at exactly who is most affected by COVID-19. In a new study published for the CDC's Morbidity and Mortality Weekly Report, researchers found that the majority of those hospitalized due to COVID-19 have preexisting conditions—about 90% of patients, or nearly all, had one or more underlying conditions. The most common ... include hypertension (49.7%), obesity (48.3%), chronic lung disease (34.6%), diabetes mellitus (28.3%), and cardiovascular disease (27.8%). The data collected for the study came from the COVID-19–Associated Hospitalization Surveillance Network (COVID-NET), created for population-based surveillance for all confirmed COVID-19–related hospitalizations in the US. The CDC's new study used the demographics of 1,482 COVID-19 patients ... from across 14 different states. The study found that 74.5% of those hospitalized due to coronavirus were age 50 or older, with the highest rates among those over 65. Men were also disproportionately affected (54.4% of those hospitalized from COVID-19 were male), as were African Americans, who represented 33% of hospitalizations, despite only making up 18% of the total population studied.

Note: For more along these lines, see concise summaries of deeply revealing news articles on health and the coronavirus pandemic from reliable major media sources.

Keeping track of vaccinations remains a major challenge in the developing world. Now a group of Massachusetts Institute of Technology researchers has developed a novel way to address this problem: embedding the record directly into the skin. Along with the vaccine, a child would be injected with a bit of dye that is invisible to the naked eye but easily seen with a special cell-phone filter, combined with an app that shines near-infrared light onto the skin. The dye would be expected to last up to five years, according to tests on pig and rat skin and human skin in a dish. The system - which has not yet been tested in children - would provide quick and easy access to vaccination history ... according to the study. Delivering the dye required the researchers to find something that was safe and would last long enough to be useful. The team ended up using a technology called quantum dots, tiny semiconducting crystals that reflect light and were originally developed to label cells during research. The work was funded by the Bill & Melinda Gates Foundation and came about because of a direct request from Microsoft founder and philanthropist Bill Gates himself. The researchers hope to add more detailed information to the dots, such as the date of vaccination. Along with them, the team eventually wants to inject sensors that could also potentially be used to track aspects of health such as insulin levels in diabetics.

Note: Bill Gates insists he never said we'd need digital vaccine passports. Yet researchers have found that his TED Talk which included this statement was edited to remove it. You can prove this with the evidence provided on this webpage. For more along these lines, see concise summaries of deeply revealing news articles on vaccines and microchip implants from reliable major media sources.

About a half a dozen journalists were in a northern California courtroom to cover a third lawsuit alleging that Monsanto’s pesticide glyphosate causes cancer. [Sylvie] Barak told others that she was a freelancer for the BBC. When journalists searched the internet for Barak, they noticed that her LinkedIn account said she worked for FTI Consulting, a global business advisory firm that Monsanto and Bayer, Monsanto’s parent company, had engaged for consulting. Monsanto has also previously employed shadowy networks of consultants, PR firms, and front groups to spy on and influence reporters. And all of it appears to be part of a pattern at the company of using a variety of tactics to intimidate, mislead and discredit journalists and critics. In the latest example of Monsanto’s efforts to track journalists, The Guardian reported in August on internal documents from the company’s “fusion center,” which worked to discredit reporters and nonprofits via third-party actors. In the California trial, the reporter who first identified Barak as an FTI plant said she ... saw an uptick in Monsanto’s industry partners contacting her as she covered the trial. A guy named Jay Byrne ... contacted her on social media to discuss how GMO criticism was part of a Russian influence campaign; when she Googled Byrne, she learned he is Monsanto’s former director of communications. In a January deposition, a Monsanto representative said that in 2016 the company spent “around $16 or 17 million” on activities to defend glyphosate.

Note: Major lawsuits are now unfolding over Monsanto's lies to regulators and the public on the dangers of glyphosate. Yet the EPA continues to use industry studies to declare Roundup safe while ignoring independent scientists. For more along these lines, see concise summaries of deeply revealing news articles on corporate corruption from reliable major media sources.

Jack Tibbetts, a member of the Santa Rosa, Calif., city council, knew he had a problem. It was early 2018, and he’d started getting calls from constituents at opposite ends of the political spectrum. The common thread: cellular antennas going up next to their homes, causing concerns over property values and health. Cities and towns throughout Northern California are issuing ordinances that would exclude new 5G cell sites from residential areas, citing ... health concerns. Residents of Portland, Ore., and Whitefish, Mont., have also cited these beliefs while lobbying for restrictions. Legislators in four states including New Hampshire have proposed bills that would mandate further study of health effects or else urge Congress to do so, and Congressman Thomas Suozzi (D., N.Y.) wrote to the FCC echoing these concerns. For Mr. Tibbetts, it didn’t matter whether or not these new “small cell” antennas ... going up in Santa Rosa were actually dangerous. What mattered was that his constituents didn’t want these ungainly chunks of public infrastructure anywhere near them. Whatever the basis for residents’ objections to new cell towers, Mr. Tibbetts - as well as countless mayors, governors and council members across the country - have little or no power under current rules to act on their constituents’ wishes. Those who do take action are creating ordinances that put their cities at risk of being sued by the telecoms, as happened this month in Rochester, N.Y..

Note: You can find the full article on this webpage. For more along these lines, see concise summaries of deeply revealing news articles on the risks and dangers of wireless technologies from reliable major media sources.

Important Note: Explore our full index to revealing excerpts of key major media news articles on several dozen engaging topics. And don't miss amazing excerpts from 20 of the most revealing news articles ever published.